Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:67951rdf:typepubmed:Citationlld:pubmed
pubmed-article:67951lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:67951lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:67951lifeskim:mentionsumls-concept:C0221284lld:lifeskim
pubmed-article:67951lifeskim:mentionsumls-concept:C0301896lld:lifeskim
pubmed-article:67951lifeskim:mentionsumls-concept:C0205359lld:lifeskim
pubmed-article:67951lifeskim:mentionsumls-concept:C0439801lld:lifeskim
pubmed-article:67951lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:67951pubmed:issue3lld:pubmed
pubmed-article:67951pubmed:dateCreated1977-7-29lld:pubmed
pubmed-article:67951pubmed:abstractTextNonadherent and nonphagocytic lymphoid cells from human peripheral blood became strongly cytotoxic against 51Cr-labeled chicken red blood cells and cells from an established human myeloma cell line when subjected to repeated cycles of washing in phosphate buffered saline or treated with trypsin or lecithinase. Prior to augmentation the effector cells pass nylon wool columns that remove practically all surface IgG-positive cells, but after augmentation they are retained in such columns. Augmentation does not make them phagocytic or adherent to plastic surfaces. Incubation at 37 degrees C of augmented cells prior to addition on the target cells restores the original nonaggressive state. Morphologically the cells making contact with the target cells are small or intermediate-sized mononuclear cells.lld:pubmed
pubmed-article:67951pubmed:languageenglld:pubmed
pubmed-article:67951pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:67951pubmed:citationSubsetIMlld:pubmed
pubmed-article:67951pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:67951pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:67951pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:67951pubmed:statusMEDLINElld:pubmed
pubmed-article:67951pubmed:monthMarlld:pubmed
pubmed-article:67951pubmed:issn0014-2980lld:pubmed
pubmed-article:67951pubmed:authorpubmed-author:MäkeläOOlld:pubmed
pubmed-article:67951pubmed:authorpubmed-author:SakselaEElld:pubmed
pubmed-article:67951pubmed:authorpubmed-author:ImirTTlld:pubmed
pubmed-article:67951pubmed:issnTypePrintlld:pubmed
pubmed-article:67951pubmed:volume7lld:pubmed
pubmed-article:67951pubmed:ownerNLMlld:pubmed
pubmed-article:67951pubmed:authorsCompleteYlld:pubmed
pubmed-article:67951pubmed:pagination126-30lld:pubmed
pubmed-article:67951pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Hu...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-An...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Le...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Ph...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Tr...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Ep...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Ch...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Ti...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Ce...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Ce...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Im...lld:pubmed
pubmed-article:67951pubmed:meshHeadingpubmed-meshheading:67951-Cy...lld:pubmed
pubmed-article:67951pubmed:year1977lld:pubmed
pubmed-article:67951pubmed:articleTitleSpontaneous, augmentable cell-mediated cytotoxicity with limited target cell specificity in human blood.lld:pubmed
pubmed-article:67951pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:67951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:67951lld:pubmed